The Wound Healing Society (WHS) is a professional society of physicians, nurses, physical therapists, podiatrists, and other wound care specialists, basic scientists, clinical researchers, and industrial researchers dedicated to assuring that every patient receives optimal wound care. Its mission is to advance the science and practice of wound healing. To that end, the following comprehensive, evidence-and consensus-based guidelines were developed to address The Prevention of Diabetic Ulcers. The guidelines are presented in generic terms; the details of specific tests, therapies, and procedures are at the discretion of an interdisciplinary team of health care professionals who establish, implement, and evaluate policies and procedures directed at prevention of diabetic ulcers.
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METHODS
PubMed, EMBASE, CINAHL, and the Cochrane Database of Systematic Reviews were searched and reviewed for evidence on arterial insufficiency ulcer prevention. In addition, a search of health care databases for current evidence-based guidelines addressing the prevention of diabetic ulcers was conducted using electronic and online resources. The panel classified studies based on whether the intervention being evaluated addressed diabetic ulcer risk screening and assessment, diabetic ulcer prevention plans of care (including interdisciplinary approaches), or patient and caregiver education.
Evidence references for each standard are listed and coded. The code abbreviations for the evidence citations were as follows: Guideline #1.2: The presence of significant neuropathy that can render a patient at risk of foot ulceration can be determined by testing with a 10 g (5.07) Semmes-Weinstein monofilament. Monofilament testing should be combined with a clinical examination of the lower extremity that focuses on the possible existence of foot deformity and a symmetric sensory level below which there is reduced sensation to pain, touch and vibration in both limbs.
Level of Evidence: II.
Principle: The most important causative factor of diabetic foot ulcers is peripheral neuropathy. Neuropathy leads to foot deformity with abnormal pressure on the foot, especially the plantar surface. Lack of protective sensation allows ulceration in areas of high pressure. Autonomic neuropathy may increase the likelihood of skin breakdown.
Evidence: 
Principle: High glucose concentrations in the blood lead to increased glycation of the hemoglobin molecules to form hemoglobin A1C, which persists in circulation for up to 6 weeks. Therefore, measurement of plasma hemoglobin A1C is the accepted standard for monitoring long-term glucose control. Elevated hemoglobin A1C levels have been correlated with a variety of comorbidities of diabetes, such as cardiovascular and/or coronary heart disease, retinopathy, neuropathy, and nephropathy/renal failure. Elevated hemoglobin A1C has been shown to be a predictive factor in the development of diabetic foot ulcers but further research is still required. 
Level of Evidence: I.
Principle: Published guidelines uniformly recommend that all diabetic patients have an annual foot examination that includes assessment for anatomic deformities, skin breaks, nail disorders, loss of protective sensation, diminished arterial supply, and improper footwear. People with higher risk for foot ulceration should have more frequent foot exams.
Protect the Diabetic Foot:
Guideline #4.1: Protective footwear should be prescribed in any patient at risk for ulceration (significant arterial insufficiency, significant neuropathy, or previous amputation).
Level of Evidence: II.
Principle: Diabetic ulceration may result from an increase in pressure in the diabetic foot because of foot deformity and neuropathy. Offloading reduces the area of high pressure. The incidence of ulceration in diabetic patients at risk can be reduced by using protective footwear. Protective footwear should be prescribed in any patient at risk for amputation (such as significant arterial insufficiency, significant neuropathy, previous amputation, previous ulcer formation, pre-ulcerative callus, foot deformity, or evidence of callus formation).
Evidence:
